Delivery Order SPE2DB22D2007-SPE2DB24FJ3JL
- Not listed
- This federal contract award, valued at $3,153.36, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of a specific pharmaceutical product, QSYMIA 3.75 MG-23 MG capsules, with an ultimate completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $6,070.08, was issued by the Department of Defense's Medical Supply Chain (also known as the Defense Logistics Agency Troop Support Medical) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract is for the delivery of 4564800154 QSYMIA 7.5 MG-46 MG CAPSULE 30S, a prescription medication, with a completion date of June 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,478.55, is for the delivery of the pharmaceutical product QSYMIA 7.5MG-46MG 30S. It is a firm fixed-price Delivery Order with a completion date of July 12, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a Delivery Order valued at $4,479.23 for the provision of the prescription drug QSYMIA 3.75 MG-23 MG CAPSULE 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 29, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Qsymia 7.5mg-46mg in 30-count packages. The contract has a ceiling value of $1,463.52 and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, provides Qsymia 7.5 mg-46 mg capsules to the Defense Logistics Agency (DLA). The $1,245.70 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and the DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a range of pharmaceutical products...
- This federal contract award, with an ID of SPE2DB22D3501|SPE2DB24FXA05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,180.33 firm-fixed-price delivery order is for the supply of QSYMIA 3.75 MG-23 MG capsules, a pharmaceutical product. The contract has an ultimate completion date of September 19, 2024. Amerisourcebergen, a major pharmaceutical distributor in the United States, has been awarded multiple indefinite delivery...
- The U.S. government awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug QSYMIA 7.5MG-46MG 30S. The contract, valued at $1,663.14, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a unit of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025, which serves as the...
- This federal contract award, with a ceiling value of $2,073.32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product QSYMIA 7.5 MG-46 MG CAPSULE 30S. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,038.20 firm-fixed-price delivery order is for the supply of Qsymia 7.5 mg-46 mg capsules. The order has an ultimate completion date of August 12, 2024. Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical and the Department of Justice Federal...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ3JLDelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product QSYMIA 7.5 MG-46 MG CAPSULE 30S. The contract, valued at $1,274.90, was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This specific contract award does not have a set-aside designation, indicating it was awarded on a full and open competition basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 6/13/24 |